These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

537 related items for PubMed ID: 17112298

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy.
    Faltaos DW, Hulot JS, Urien S, Morel V, Kaloshi G, Fernandez C, Xuan kH, Leblond V, Lechat P.
    Cancer Chemother Pharmacol; 2006 Nov; 58(5):626-33. PubMed ID: 16528531
    [Abstract] [Full Text] [Related]

  • 3. [Population pharmacokinetics of high-dose methotrexate administered in 329 children with acute lymphoblastic leukemia].
    Zhang CY, Gu J, Li YZ, Lu W.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):106-10. PubMed ID: 18315911
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Population pharmacokinetic study of methotrexate in children with acute lymphoblastic leukemia.
    Zhang C, Zhai S, Yang L, Wu H, Zhang J, Ke X.
    Int J Clin Pharmacol Ther; 2010 Jan; 48(1):11-21. PubMed ID: 20040335
    [Abstract] [Full Text] [Related]

  • 8. High-dose methotrexate in adults with osteosarcoma: a population pharmacokinetics study and validation of a new limited sampling strategy.
    Dupuis C, Mercier C, Yang C, Monjanel-Mouterde S, Ciccolini J, Fanciullino R, Pourroy B, Deville JL, Duffaud F, Bagarry-Liegey D, Durand A, Iliadis A, Favre R.
    Anticancer Drugs; 2008 Mar; 19(3):267-73. PubMed ID: 18510172
    [Abstract] [Full Text] [Related]

  • 9. A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia.
    Plard C, Bressolle F, Fakhoury M, Zhang D, Yacouben K, Rieutord A, Jacqz-Aigrain E.
    Cancer Chemother Pharmacol; 2007 Sep; 60(4):609-20. PubMed ID: 17195068
    [Abstract] [Full Text] [Related]

  • 10. Methotrexate pharmacokinetics in childhood acute lymphoblastic leukaemia: a prognostic value?
    Martelli N, Mathieu O, Margueritte G, Bozonnat MC, Daurès JP, Bressolle F, Hillaire-Buys D, Peyrière H.
    J Clin Pharm Ther; 2011 Apr; 36(2):237-45. PubMed ID: 21366654
    [Abstract] [Full Text] [Related]

  • 11. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P, Oviedo I, Campbell M, Tordecilla J.
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [Abstract] [Full Text] [Related]

  • 12. Population pharmacokinetics of methotrexate in Mexican pediatric patients with acute lymphoblastic leukemia.
    Medellin-Garibay SE, Hernández-Villa N, Correa-González LC, Morales-Barragán MN, Valero-Rivera KP, Reséndiz-Galván JE, Ortiz-Zamudio JJ, Milán-Segovia RDC, Romano-Moreno S.
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):21-31. PubMed ID: 31673826
    [Abstract] [Full Text] [Related]

  • 13. A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma.
    Johansson ÅM, Hill N, Perisoglou M, Whelan J, Karlsson MO, Standing JF.
    Ther Drug Monit; 2011 Dec; 33(6):711-8. PubMed ID: 22105588
    [Abstract] [Full Text] [Related]

  • 14. Pharmacokinetics of HD-MTX in infants, children, and adolescents with non-B acute lymphoblastic leukemia.
    Donelli MG, Zucchetti M, Robatto A, Perlangeli V, D'Incalci M, Masera G, Rossi MR.
    Med Pediatr Oncol; 1995 Mar; 24(3):154-9. PubMed ID: 7838036
    [Abstract] [Full Text] [Related]

  • 15. [Investigation on individualized adjustment of target range of high-dose methotrexate].
    Hua Y, Zhao WH, Lu XT, Yang LH, Lu W.
    Zhonghua Er Ke Za Zhi; 2008 Mar; 46(3):203-8. PubMed ID: 19099710
    [Abstract] [Full Text] [Related]

  • 16. Population pharmacokinetics of high-dose methotrexate in Japanese adult patients with malignancies: a concurrent analysis of the serum and urine concentration data.
    Fukuhara K, Ikawa K, Morikawa N, Kumagai K.
    J Clin Pharm Ther; 2008 Dec; 33(6):677-84. PubMed ID: 19138246
    [Abstract] [Full Text] [Related]

  • 17. Population pharmacokinetics of doxorubicin: establishment of a NONMEM model for adults and children older than 3 years.
    Kontny NE, Würthwein G, Joachim B, Boddy AV, Krischke M, Fuhr U, Thompson PA, Jörger M, Schellens JH, Hempel G.
    Cancer Chemother Pharmacol; 2013 Mar; 71(3):749-63. PubMed ID: 23314734
    [Abstract] [Full Text] [Related]

  • 18. High-dose methotrexate in children with acute lymphoblastic leukemia: 7-hydroxymethotrexate systemic exposure and urinary concentrations at the steady state correlate well with those of methotrexate.
    Chládková J, Hak J, Martínková J, Chládek J.
    Arzneimittelforschung; 2010 Mar; 60(12):769-75. PubMed ID: 21265469
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.